• Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Biotech

Biotech

Page 16 of 19

MSMB Capital Management CIO Martin Shkreli
Health

This super-expensive drug is getting a $1 rival

By Benjamin Snyder
October 23, 2015
Big pharma won’t stay silent in drug pricing debate for long
Health

Big pharma won’t stay silent in drug pricing debate for long

By Erika Fry
October 22, 2015
Biogen Idec Inc. CEO George Scangos Interview
Health

Profits up, Biogen cuts 11% of global workforce

By Erika Fry
October 21, 2015
Hillary Clinton in the first Democratic presidential debate in Las Vegas on Oct. 13
Commentary

Clinton’s big pharma takedown plan has some serious issues

By Chris Ford and Bethany Cianciolo
October 16, 2015
Theranos controversy has little to do with ‘unicorns’
Tech

Theranos controversy has little to do with ‘unicorns’

By Dan Primack
October 15, 2015
Monsanto slashing 2,600 jobs as corn sales slide
Careers

Monsanto slashing 2,600 jobs as corn sales slide

By Benjamin Snyder
October 7, 2015
Symbolic - biotechnology - genetic engineering
Health

TPP trade deal: Even more bad news for biotech industry

By Laura Lorenzetti
October 5, 2015
Symbolic - biotechnology - genetic engineering
Finance

Biotech stock shock isn’t affecting startup deals or prices

By Dan Primack
October 2, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health

Biotech stocks dive as lawmakers take aim at Valeant for drug price hikes

By Laura Lorenzetti
September 28, 2015
Biotech stocks fall into bear market territory
Finance

Biotech stocks fall into bear market territory

By Jen Wieczner
September 25, 2015
Picture taken on January 15, 2012 in Lil
Health

This 62-year-old drug just got 5,000% more expensive

By Laura Lorenzetti
September 21, 2015
IBM pushes Watson into healthcare with new business unit
Tech

IBM pushes Watson into healthcare with new business unit

By Barb Darrow
September 10, 2015
block of rubber from Guayule plant
Tech

How leaf blight could destroy the global economy

By David Z. Morris
August 28, 2015
JAN 20th 2012.pics of . with this cold spell the 54th annual Toronto International Boat Show is wrap
Tech

It’s time to teach the new dogs old tricks

By Adam Lashinsky
August 24, 2015
A Teva Pharmaceutical Industries factory in Jerusalem, Israel.
Finance

The real reasons for the pharma merger boom

By Jen Wieczner
July 28, 2015

Most Popular

  • Success
    The scientist who helped create AI says it’s only ‘a matter of time’ before every single job is wiped out—even safer...
    By Orianna Rosa Royle
  • Success
    As graduates face a ‘jobpocalypse,’ Goldman Sachs exec tells Gen Z they need to know their commercial impact 
    By Preston Fore
  • Economy
    The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
    By Nick Lichtenberg
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.